Mirxes, a spin-off of Singapore ’s Agency for Science, Technology and Research, will establish a foothold in Hong Kong this year to tap into the vast multi-cancer early-stage screening market in the Greater Bay Area.
The renowned scientist and doctor also shares with us his new partnership with Hong Kong biotech company Prenetics, which will see the development of affordable DNA tests that can detect multiple forms of cancer.
The molecular biologist who pioneered non-invasive prenatal testing will launch a blood test kit with Hong Kong's Prenetics Group to screen for cancer cells, a game-changing approach to detect one of humankind's biggest killer diseases and propel the city's role as a research and development hub for life sciences. Professor Dennis Lo Yuk-ming of the Chinese University of Hong Kong (CUHK) and Prenetics will establish a US$200 million venture called Insighta to provide clinically administered bloo